BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18566801)

  • 1. Time to rehospitalization in patients with bipolar I disorder on lithium or valproate with adjunctive antipsychotics.
    Lin CH; Huang CW; Chen CC; Hsu YF; Chang WH; Lane HY
    Psychopharmacology (Berl); 2008 Oct; 200(2):301-3. PubMed ID: 18566801
    [No Abstract]   [Full Text] [Related]  

  • 2. One-year rehospitalization rates of patients with first-episode bipolar mania receiving lithium or valproate and adjunctive atypical antipsychotics.
    Woo YS; Bahk WM; Jung YE; Jeong JH; Lee HB; Won SH; Lee KH; Jon DI; Yoon BH; Kim MD; Min KJ
    Psychiatry Clin Neurosci; 2014 Jun; 68(6):418-24. PubMed ID: 24506520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium vs valproate in the maintenance treatment of bipolar I disorder: A post- hoc analysis of a randomized double-blind placebo-controlled trial.
    Kang MG; Qian H; Keramatian K; Chakrabarty T; Saraf G; Lam RW; Wong H; Yatham LN
    Aust N Z J Psychiatry; 2020 Mar; 54(3):298-307. PubMed ID: 31845587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paliperidone extended-release as adjunctive therapy to lithium or valproate in the treatment of acute mania: a randomized, placebo-controlled study.
    Berwaerts J; Lane R; Nuamah IF; Lim P; Remmerie B; Hough DW
    J Affect Disord; 2011 Mar; 129(1-3):252-60. PubMed ID: 20947174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic adjunctive therapy to mood stabilizers and 1-year rehospitalization rates in bipolar disorder: A cohort study.
    Hochman E; Krivoy A; Schaffer A; Weizman A; Valevski A
    Bipolar Disord; 2016 Dec; 18(8):684-691. PubMed ID: 27933713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproate v. lithium in the treatment of bipolar disorder in clinical practice: observational nationwide register-based cohort study.
    Kessing LV; Hellmund G; Geddes JR; Goodwin GM; Andersen PK
    Br J Psychiatry; 2011 Jul; 199(1):57-63. PubMed ID: 21593515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic evidence for manic episode].
    Terao T
    Seishin Shinkeigaku Zasshi; 2011; 113(9):867-72. PubMed ID: 22117391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bipolar drug development: are we getting closer to the real world?
    Calabrese JR; Kemp DE
    Am J Psychiatry; 2008 Oct; 165(10):1234-6. PubMed ID: 18829876
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination treatment with quetiapine in bipolar disorder patients.
    Basu D; Chakraborty K
    Am J Psychiatry; 2009 Oct; 166(10):1185; author reply 1186-7. PubMed ID: 19797447
    [No Abstract]   [Full Text] [Related]  

  • 10. Bipolar disorder.
    Belmaker RH
    N Engl J Med; 2004 Jul; 351(5):476-86. PubMed ID: 15282355
    [No Abstract]   [Full Text] [Related]  

  • 11. A double-blind, placebo-controlled study with quetiapine as adjunct therapy with lithium or divalproex in bipolar I patients with coexisting alcohol dependence.
    Stedman M; Pettinati HM; Brown ES; Kotz M; Calabrese JR; Raines S
    Alcohol Clin Exp Res; 2010 Oct; 34(10):1822-31. PubMed ID: 20626727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical comorbidity, acute medical care use in late-life bipolar disorder: a comparison of lithium, valproate, and other pharmacotherapies.
    Rej S; Yu C; Shulman K; Herrmann N; Fischer HD; Fung K; Gruneir A
    Gen Hosp Psychiatry; 2015; 37(6):528-32. PubMed ID: 26254672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study.
    Loebel A; Cucchiaro J; Silva R; Kroger H; Sarma K; Xu J; Calabrese JR
    Am J Psychiatry; 2014 Feb; 171(2):169-77. PubMed ID: 24170221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term therapy of bipolar illness.
    Keck PE
    J Fam Pract; 2003 Mar; Suppl():S18-21. PubMed ID: 12676080
    [No Abstract]   [Full Text] [Related]  

  • 15. Treating acute mania.
    Frye MA; Gitlin MJ; Altshuler LL
    J Fam Pract; 2003 Mar; Suppl():S10-3. PubMed ID: 12676078
    [No Abstract]   [Full Text] [Related]  

  • 16. New trial should clarify lithium use in bipolar disorder.
    Geddes J; Goodwin G; Rendell J; Hainsworth J; Van der Gucht E; Young H
    BMJ; 2002 Aug; 325(7361):441. PubMed ID: 12193365
    [No Abstract]   [Full Text] [Related]  

  • 17. A new BALANCE in bipolar I disorder.
    Licht RW
    Lancet; 2010 Jan; 375(9712):350-2. PubMed ID: 20092883
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
    Vieta E; Owen R; Baudelet C; McQuade RD; Sanchez R; Marcus RN
    Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing the rehospitalization risk after a manic episode: A population based cohort study of lithium, valproate, olanzapine, quetiapine and aripiprazole in monotherapy and combinations.
    Wingård L; Bodén R; Brandt L; Tiihonen J; Tanskanen A; Kieler H; Andersen M; Reutfors J
    J Affect Disord; 2017 Aug; 217():16-23. PubMed ID: 28364619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risperidone plus lithium versus risperidone plus valproate in acute and continuation treatment of mania.
    Yatham LN; Binder C; Kusumakar V; Riccardelli R
    Int Clin Psychopharmacol; 2004 Mar; 19(2):103-9. PubMed ID: 15076019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.